Evidence map›Paper›PMID 36014495›Full record

ArticleMolecules (Basel, Switzerland)2022

Tri- and Pentacyclic Azaphenothiazine as Pro-Apoptotic Agents in Lung Carcinoma with a Protective Potential to Healthy Cell Lines.

Magdalena Skonieczna, Anna Kasprzycka, Małgorzata Jeleń, Beata Morak-Młodawska

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Magdalena SkoniecznaBiotechnology Centre, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0002-6263-9585
Anna KasprzyckaBiotechnology Centre, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0002-9362-719X
Małgorzata JeleńDepartment of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, The Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.ORCID 0000-0002-4144-990X
Beata Morak-MłodawskaDepartment of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, The Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland.ORCID 0000-0001-5389-1079
Medical University of Silesia · PLSilesian University of Technology · PL

Funding

Medical University of Silesia PCN-1-006/N/1/F; PCN-1-007/N/1/FSilesian University of Technology in Gliwice, Poland; No 02/040/SDU/10-21-01;
6 · The paper itself

Abstract

The phenothiazine derivatives, tricyclic 10

Indexed as

Antineoplastic AgentsCarcinomaLung NeoplasmsApoptosisCell LineCell Line, TumorCell ProliferationHumansLungPhenothiazinesAntineoplastic AgentsazaphenothiazinePhenothiazinesanticancer activityapoptosisBEAS-2B and healthy NHDF cell linescancer cell lines A549 and H1299dipyridothiazinediquinothiazinelong-term live cell observations

Identifiers

PMID36014495
PMCPMC9413739
OpenAlexW4293065060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.